Prime plus blood gas analyzers mamc
Ended Awarded Last action
- Contract number
- W81K0225FA090
- Awardee
-
Nova Biomedical Corp UEI LCFDHTGXB5J3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $33,000
Award facts
- Contract value 100% obligated
- $33,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- LEWIS MCCHORD, WA 98431, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $33,000 delivery order to Nova Biomedical Corp for Prime Plus blood gas analyzers to support medical operations at Lewis-McChord in Washington. This firm fixed-price contract, with an ultimate completion date of August 25, 2025, was awarded on June 24, 2025, without a set-aside designation, reflecting Nova Biomedical's status as a large business capable of competing in open federal procurement. The delivery order represents a call against a larger indefinite delivery vehicle, leveraging Nova Biomedical's established capabilities as a critical supplier of point-of-care diagnostic equipment to the Defense Health Agency's military healthcare facilities.
Nova Biomedical Corp, headquartered in Waltham, Massachusetts, is a privately-owned manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices specializing in blood gas analyzers and related consumables. As a registered federal contractor since 2001, the company has secured substantial contracts across multiple federal health agencies, including the Department of Veterans Affairs, National Institutes of Health, and the Defense Health Agency, providing essential diagnostic equipment to military, veteran, and civilian government healthcare facilities. This award demonstrates the Defense Health Agency's continued reliance on Nova Biomedical as a qualified, stable supplier of critical diagnostic equipment to support military medical operations.
Quick answers
Who was awarded contract W81K0225FA090?
W81K0225FA090 was awarded to Nova Biomedical Corp by Medical Command (Department of the Army) on June 24, 2025.
How much is contract W81K0225FA090 worth?
The government has obligated $33,000 on W81K0225FA090.
Which agency awarded contract W81K0225FA090?
Medical Command (Department of the Army) awarded W81K0225FA090, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0225FA090 an order under another contract?
Yes. W81K0225FA090 is a delivery order under GS07F118CA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract W81K0225FA090 competed?
The extent of competition for W81K0225FA090 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award